Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India's RFCL Braves Into The Stronghold Of MNCs With High-end Diagnostics; Will It Become The Next Takeover Candidate?

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Having identified a distinct cost advantage over its bigger Western counterparts, RFCL - India's largest in-vitro diagnostics and laboratory solutions firm - is branching out into the manufacture of high-end diagnostic products used for immunoassays, a range of molecular diagnostic kits and theranostics, bringing it a step closer toward personalized medicine

You may also be interested in...



After Buying Vetnex, Pfizer Invests $40 Million To Set Up Discovery Research Center For Animal Health Drugs In India

MUMBAI - When Pfizer's $3.5 billion animal health unit made a resolute bid last June to acquire Vetnex - a small but growing Indian veterinary care company - it took industry watchers by surprise, but a well-crafted, elaborate plan was stealthily being executed

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

LL1132553

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel